 | Up a level |
Kieninger, E; Vareille, M; Kopf, BS; Blank, F; Alves, MP; Gisler, FM; Latzin, P; Casaulta, C; Geiser, T; Johnston, SL; Edwards, MR; Regamey, N (2012). Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. European respiratory journal, 39(2), pp. 297-304. Sheffield, UK: European Respiratory Society 10.1183/09031936.00054511
Brill, AK; Seifert, E; Geiser, T; Ott, SR (2012). A red flag in sarcoidosis: "Laryngeal obstruction". Respiration, 84((5)), pp. 429-30. Basel: Karger 10.1159/000340036
Brill, AK; Kunz, A; Ott, SR; Geiser, T; Pichler, J (2012). When high is not high enough - High altitude edema in sarcoidosis. High altitude medicine & biology, 13((4)), pp. 285-7. Larchmont, N.Y.: Mary Ann Liebert 10.1089/ham.2012.1044
Brill, AK; Ott, SR; Geiser, T (2012). Mycophenolat mofetil als steroidsparende Therapie der chronischen pulmonalen Sarkoidose. Pneumologie, 66, p. 90. Stuttgart: Thieme
Engler, K; Mühlemann, K; Garzoni, C; Pfahler, H; Geiser, T; von Garnier, C (2012). Colonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patients. Swiss medical weekly, 142:0 Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13509
Hradetzky, D; Boehringer, S; Geiser, T; Gazdhar, A (2012). An approach towards bronchoscopic-based gene therapy using electrical field accelerated plasmid droplets. IEEE Engineering in Medicine and Biology Society conference proceedings, pp. 5753-6. Piscataway, N.J.: IEEE Service Center
von Garnier, C; Geiser, T (2011). Comment on "Pre- and intra-operative mediastinal staging in non-small-cell lung cancer. Swiss medical weekly, Nov 21, p. 141. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13289
Blank, F; Gerber, P; Rothen-Rutishauser, B; Sakulkhu, U; Salaklang, J; de Peyer, K; Gehr, P; Nicod, LP; Hofmann, H; Geiser, T; Petri-Fink, A; von Garnier, C (2011). Biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. Nanotoxicology(Jan 2011) London: Informa Healthcare
Rothen-Rutishauser, B; Blank, F; Petri-Fink, A; Clift, MJ; Geiser, T; von Garnier, C (2011). Laser scanning microscopy combined with image restoration to analyse and quantify the intracellular localisation of fluorescently labelled nanoparticles. Imaging & microscopy Weinheim: GIT-Verlag
Ugi, J; Lepper, PM; Witschi, M; Maier, V; Geiser, T; Ott, SR (2010). Non-resolving pneumonia and rash in an adult: pulmonary involvements in Kawasaki's disease. European respiratory journal, 35(2), pp. 452-454. Sheffield, UK: European Respiratory Society 10.1183/09031936.00132309
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Geiser, T; Nicod, LP; von Garnier, C (2010). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. American journal of respiratory and critical care medicine, 181(A3096) New York, N.Y.: American Lung Association
Kaufmann, M; Geiser, T; Gugger, M; Nicod, LP (2008). Tracheobronchiales Sklerom bei einer Patientin mit zentraler Atemwegsobstruktion. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, -8(18-19), pp. 343-345. Basel: EMH Editores Medicorum Helveticorum
Knudsen, L; Geiser, T (2008). Pathogenesis and diagnostic work-up of patients with idiopathic pulmonary fibrosis. Respiratory medicine, 101(12), pp. 2534-2540. London: Elsevier 10.1016/j.rmed.2007.07.012
Baltensperger, U; Dommen, J; Rami Alfarra, M; Duplissy, J; Gaeggeler, K; Metzger, A; Facchini, MC; Decesari, S; Finessi, E; Geiser, Marianne; Savi, M; Lang, D; Kalberer, M; Geiser, T (2008). Combined Determination of the Chemical Composition and of Health Effects of Secondary Organic Aerosols: the POLYSOA Project. Journal of aerosol medicine - deposition, clearance, and effects in the lung, 21(1), pp. 145-154. New York, N.Y.: Mary Ann Liebert 10.1089/jamp.2007.0655
Ulrich, S; Speich, R; Domenighetti, G; Geiser, T; Aubert, JD; Rochat, T; Huber, L; Treder, U; Fischler, M (2007). Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss medical weekly, -137(41-42), pp. 573-80. Muttenz: EMH Schweizerischer Ärzteverlag
Bastarache, JA; Wang, L; Geiser, T; Wang, Z; Albertine, KH; Matthay, MA; Ware, LB (2007). The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax, -62(7), pp. 563-4. London: BMJ Publishing Group 10.1136/thx.2006.063305
Geiser, T; et, al (2008). Pneumologie. In: (pp. 307-396). D&F GmbH
Brill, AK; Ott, SR; Geiser, T (2012). Mycofenolat Mofetil als steroidsparende Therapie der chronischen pulmonalen Sarkoidose. In: 53. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. D - Nürnberg: 53. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin
Cleven, J; Vogelsinger, H; Ott, S; Geiser, T; Halank, M; Kahler, CM (2012). Effect transnasaler "High-Flow-Sauerstoff-Insufflation" bei Patienten mit schwerer COPD. In: Pneumo Update Conference. Innsbruck: Pneumo Update Conference
Vogelsinger, H; Cleven, J; Ott, S; Geiser, T; Halank, M; Kahler, CM (2012). STIT-1: Eine Investigator-initiierte, prospektive Multicenter-Studie. Sicherheit und Effizienz von kurzzeitiger "High-Flow-Insufflation" bei Patienten mit schwerer COPD, evaluiert anhand von Lungenfunktionsparametern. In: Pneumo Update Conference. Innsbruck: Pneumo Update Conference
Vogelsinger, H; Cleven, J; Ott, S; Geiser, T; Halank, M; Kahler, CM (2012). STIT-1: Eine Investigator-initiierte, prospektive Multicenter-Studie. Sicherheit und Effizienz von kurzzeitiger "High-Flow-Insufflation" bei Patienten mit schwerer COPD, evaluiert anhand von Lungenfunktionsparametern. In: Jahreskongress European Respiratory Society. Amsterdam: Jahreskongress European Respiratory Society
Hradetzky, D; Boehringer, S; Geiser, T; Gazdhar, A (2012). An approach towards bronchoscopic-based gene therapy using electrical field accelerated plasmid doplets. In: IEEE conference. USA - San Diego: IEEE conference
Gazdhar, A; Grad, I; Gugger, M; Feki, A; Geiser, T (2012). iPS cell reduce bleomycin induced fibrosis in rat lung. In: Jahresversammlung Schweizerische Gesellschaft für Pneumologie. Montana: Jahresversammlung Schweizerische Gesellschaft für Pneumologie
Gazdhar, A; Grad, I; Gugger, M; Feki, A; Geiser, T (2012). iPS cell reduce belomycin induced fibrosis in rat lung. In: PneumoUpdate. A - Innsbruck: PneumoUpdate
Gazdhar, A; Grad, I; Gugger, M; Feki, A; Geiser, T (2012). iPS cell conditional media reduce bleomycin induced fibrosis in rat lung. In: Annual meeting European Respiratory Society. A - Vienna: Annual meeting European Respiratory Society
Gazdhar, A; Grad, I; Gugger, M; Feki, A; Geiser, T (2012). iPS cell reduce bleomycin induced fibrosis in rat lung. In: Annual meeting American Thoracic Society. USA - San Francisco: Annual meeting American Thoracic Society
Kunz, A; Pichler Hefti, J; Geiser, T; Ott, S (2011). Pulmonary Hypertension in Sarcoidosis - a case of successful treatment with immunosuppressive therapy. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011
Pichler Hefti, J; Sonntag, DU; Hefti, U; Merz, TM; Weinberger, KM; Geiser, T; Huber, AR (2011). Oxidative stress during hypobaric hypoxia and influence on vessel tone modifying mediators. In: ERS annual meeting 2011, Amsterdam. ERS annual meeting 2011, Amsterdam
Brill, AK; Herren, T; Geiser, T (2011). Treatment of pulmonary sarcoidosis with mycophenolate mofetil - An effective steroid-sparing agent? In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011
Brill, AK; Ludwig, P; Hagemann, M; Dumont, P; Geiser, T; Ott, SR (2011). A rare cause of severe airway obstruction: Laryngeal involvement in sarcoidosis. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011
Vogel, R; Blank, F; Gazdhar, A; Widmer, HR; Geiser, T; von Garnier, C (2011). Systemic distribution of biomedical nanoparticles applied via the pulmonary route. In: SGP-Jahreskongress 2011. SGP-Jahreskongress 2011
Gazdhar, A; Susuri, N; Gugger, M; Geiser, T (2011). HGF epxressing stem cells in the human fibrotic lung originate from the bone marrow and reduce bleomycin-induced pulmonary fibrosis in the rat. In: Swiss stem cell meeting. Lausanne: Swiss stem cell meeting
Gazdhar, A; Susuri, N; Gugger, M; Geiser, T (2011). HGF expressing stem cells in the human fibrotic lung originate from the bone marrow. In: Pneumo Update Conference. Innsbruck: Pneumo Update Conference
Seiler, Christof; Gazdhar, A; Geiser, T; Reyes, Mauricio; Gantenbein-Ritter, Benjamin (2010). Mesenchymal Stem Cell Classification during Differentiation Based on Shape Information (Unpublished).
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: , (ed.) Swiss Society for Pneumology. Lausanne: Swiss Society for Pneumology
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: European Respiratory Society Annual Conference. Barcelona, Spain: European Respiratory Society Annual Conference
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: 11th International Symposium on dendritic cells in fundamental and clinical immunology. Lugano.
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2010). Exposure of dendritic cells to biomedical nanoparticles decreases antigen processing capacity and specific CD4+ T cell stimulation. In: Day of clinical research at the Bern University. Bern: Day of clinical research at the Bern University
Ott, SR; Zink, A; Geiser, T (2010). Behandlung der allergischen bronchopulmonalen Aspergillose (ABPA) mit Omalizumab bei einer erwachsenen non-CF Patientin - Eine Fallbeschreibung. In: 51. Jahreskongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Hannover: 51. Jahreskongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Ott, SR; Zink, A; Geiser, T (2010). Treatment of allergic bronchopulmonary aspergillosis with Anti-IgE antibody (Omalizumab) in an asthmatic adult - a case report. In: Jahreskongress der American Thoracic Society (ATS). New Orleans: Jahreskongress der American Thoracic Society (ATS)
Vogelsinger, H; Halank, M; Braun, S; Ott, SR; Desole, S; Geiser, T; Kaehler, CM (2010). STIT-1: Evaluation of safety and efficacy of shorttime TNIR treatment in patients with COPD - first interim analysis. In: Jahreskongress der European Respiratory Society (ERS). Barcelona: Jahreskongress der European Respiratory Society (ERS)
Blank, F; von Garnier, C; Dumont, P; Sauter, K; Loosli, RH; Geiser, T (2010). High diagnostic yield of EBUS guided TBNA in the diagnosis of centrally located intrapulmonary lesions. In: Schweizerische Gesellschaft für Pneumologie. Orlando: Schweizerische Gesellschaft für Pneumologie
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Bone marrow derived stem cells attenuate bleomycin induced lung fibrosis in rat lungs. In: Swiss stem cell network meeting. Basel: Swiss stem cell network meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Modified BMSC improve lung fibrosis in bleomycin injured rat lungs. In: Annual Swiss Pulmonary Medicine Meeting. Lausanne: Annual Swiss Pulmonary Medicine Meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). Modified BMSC attenuate fibrosis in bleomycin injured rat lungs. In: European Respiratory Meeting. Barcelona: European Respiratory Meeting
Gazdhar, A; Knudsen, L; Gugger, M; Ochs, M; Geiser, T (2010). BMSC and modified BMSC as novel therapeutics for lung fibrosis. In: Pneumo Update Conference. Innsbruck: Pneumo Update Conference
Blank, F; Gerber, P; Fink, A; Rothen-Rutishauser, V; de Peyer, K; Nicod, L; Geiser, T; von Garnier, C (2009). Dendritic cells exposed to biomedical nanoparticles retain an immature like functional state and show reduced antigen specific CD4+ T cell stimulation in vitro. In: Conference of the American Thoracic Society. San Diego.
von Garnier, C; Gerber, P; Fink, A; Rothen-Rutishauser, B; de Peyer, K; Nicod, L; Geiser, T (2009). Exposure of dendritic cells to biomedical nanoparticles down-regulates antigen-specific CD4+ T cell stimulation. In: International conference of the European Respiratory Society. Wien.
Ott, S; Geiser, T (2009). Treatment of allergic bronchopulmonary aspergillosis with anti-IgE antibody (omalizumab) in an asthmatic adult. In: Jahreskongress Schweizerische Gesellschaft für Pneumologie. Davos.
Knudsen, L; Temuri, A; Gazdhar, A; Schmid, R; Ochs, M; Geiser, T (2009). The impact of human hepatocyte growth factor 8hHGF in bleomycin-induce pulmonary fibrosis - morphometric analysis. In: Pneumo Update Conference. Innsbruck.
